Cargando…
2554. What’s Weight Got to Do with It? Prospective Pharmacokinetic/Pharmacodynamic Evaluation of Fixed-Dose Daptomycin
BACKGROUND: As daptomycin (DAP) CL does not scale proportionally with weight, fixed-dose DAP has been proposed to optimize efficacy and mitigate toxicity. This study evaluated systemic exposure of a fixed dose (750 mg) of DAP in patients with Staphylococcus aureus infections. METHODS: Adult non-ICU...
Autores principales: | Olney, Katie B, Thomas, Jenni, Pai, Manjunath P, Burgess, Donna R, Olney, William, Bruning, Rebecca, Griffith, Kamron Amir, Casaus, Danielle, Crance, Elizabeth, Burgess, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677270/ http://dx.doi.org/10.1093/ofid/ofad500.2171 |
Ejemplares similares
-
973. Pharmacokinetic/Pharmacodynamic Evaluation and Dose Optimization of Daptomycin in Pediatric Patients with Staphylococcus aureus Bacteremia
por: Olney, Katie B, et al.
Publicado: (2023) -
1642. Vancomycin AUC(24) Estimation Using First Order Pharmacokinetic Methods in Pediatric Patients
por: Wallace, Katie L, et al.
Publicado: (2023) -
177. Infectious Diseases Consultation Associated with Decreased Mortality in Gram-Negative Bacteremia
por: Bruning, Rebecca, et al.
Publicado: (2023) -
Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline
por: Rodvold, Keith A, et al.
Publicado: (2019) -
Changing times: The impact of gram-negative breakpoint changes over the previous decade
por: Johnson, Wes M., et al.
Publicado: (2022)